Lin YS - Search Results

1

Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN.

Hsu YL, Hung JY, Chang WA, Jian SF, Lin YS, Pan YC, Wu CY, Kuo PL. Hsu YL, et al. Among authors: lin ys. Mol Ther. 2018 Feb 7;26(2):568-581. doi: 10.1016/j.ymthe.2017.11.016. Epub 2017 Nov 29. Mol Ther. 2018. PMID: 29292163 Free PMC article.

2

Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway.

Hsu YL, Wu CY, Hung JY, Lin YS, Huang MS, Kuo PL. Hsu YL, et al. Among authors: lin ys. Carcinogenesis. 2013 Jun;34(6):1370-81. doi: 10.1093/carcin/bgt040. Epub 2013 Feb 6. Carcinogenesis. 2013. PMID: 23389289

3

Aryl hydrocarbon receptor agonists upregulate VEGF secretion from bronchial epithelial cells.

Tsai MJ, Wang TN, Lin YS, Kuo PL, Hsu YL, Huang MS. Tsai MJ, et al. Among authors: lin ys. J Mol Med (Berl). 2015 Nov;93(11):1257-69. doi: 10.1007/s00109-015-1304-0. Epub 2015 Jun 17. J Mol Med (Berl). 2015. PMID: 26076680

4

S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.

Hsu YL, Hung JY, Liang YY, Lin YS, Tsai MJ, Chou SH, Lu CY, Kuo PL. Hsu YL, et al. Among authors: lin ys. Oncotarget. 2015 Oct 6;6(30):29585-98. doi: 10.18632/oncotarget.4987. Oncotarget. 2015. PMID: 26320193 Free PMC article.

5

Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR-30c in breast cancer.

Yen MC, Shih YC, Hsu YL, Lin ES, Lin YS, Tsai EM, Ho YW, Hou MF, Kuo PL. Yen MC, et al. Among authors: lin es, lin ys. Oncol Rep. 2016 Mar;35(3):1356-64. doi: 10.3892/or.2015.4503. Epub 2015 Dec 22. Oncol Rep. 2016. PMID: 26707189

6

Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.

Hsu YL, Hung JY, Chiang SY, Jian SF, Wu CY, Lin YS, Tsai YM, Chou SH, Tsai MJ, Kuo PL. Hsu YL, et al. Among authors: lin ys. Oncotarget. 2016 May 10;7(19):27584-98. doi: 10.18632/oncotarget.8488. Oncotarget. 2016. PMID: 27050278 Free PMC article.

7

Laricitrin ameliorates lung cancer-mediated dendritic cell suppression by inhibiting signal transducer and activator of transcription 3.

Chang WA, Hung JY, Jian SF, Lin YS, Wu CY, Hsu YL, Kuo PL. Chang WA, et al. Among authors: lin ys. Oncotarget. 2016 Dec 20;7(51):85220-85234. doi: 10.18632/oncotarget.13240. Oncotarget. 2016. PMID: 27833081 Free PMC article.

8

Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells.

Tsai MJ, Chang WA, Tsai PH, Wu CY, Ho YW, Yen MC, Lin YS, Kuo PL, Hsu YL. Tsai MJ, et al. Among authors: lin ys. Int J Mol Sci. 2017 Jun 24;18(7):1353. doi: 10.3390/ijms18071353. Int J Mol Sci. 2017. PMID: 28672809 Free PMC article.

9

Deducting MicroRNA-Mediated Changes Common in Bronchial Epithelial Cells of Asthma and Chronic Obstructive Pulmonary Disease-A Next-Generation Sequencing-Guided Bioinformatic Approach.

Tsai MJ, Tsai YC, Chang WA, Lin YS, Tsai PH, Sheu CC, Kuo PL, Hsu YL. Tsai MJ, et al. Among authors: lin ys. Int J Mol Sci. 2019 Jan 28;20(3):553. doi: 10.3390/ijms20030553. Int J Mol Sci. 2019. PMID: 30696075 Free PMC article.

10

Bone-marrow-derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic niche in lung cancer.

Hsu YL, Huang MS, Hung JY, Chang WA, Tsai YM, Pan YC, Lin YS, Tsai HP, Kuo PL. Hsu YL, et al. Among authors: lin ys. Oncogene. 2020 Jan;39(4):739-753. doi: 10.1038/s41388-019-1024-y. Epub 2019 Sep 26. Oncogene. 2020. PMID: 31558801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,297 results

Search Page

Filters